Chair: I welcome our panelists. We all know how severe this issue is – medicines are unavailable or unaffordable. This is for a variety of reasons, some of it is regulatory – lets not forget that there is a lot of weork done to optimize legislation. There is also often a lack of professional knowledge. …
International Narcotics Control Board (INCB)
CND thematic sessions on the implementation of all international drug policy commitments, following-up to the 2019 Ministerial Declaration – 21 September 2022
Multiyear Workplan 2019-2023: Implementation of all our international drug policy commitments, following up to the 2019 ministerial declaration “Strengthening Our Actions at the National, Regional and International Levels to Accelerate the Implementation of our Joint Commitments to Address and Counter the World Drug Problem” The provisional agenda for the intersessional meeting is as follows: 1. Thematic …
Side event: International Standards for Reporting Cannabis and Cannabis-related Substances for Medical Purposes
18 March 2022 at 8:00 AM- 8:50 AM Vienna Time (CET) Organised by the INCB Narcotic Control and Estimates Section with the support of Argentina, Australia, Costa Rica, Israel, Germany, Japan, the Netherlands, Paraguay, Portugal, South Africa, Spain, Switzerland, the United Kingdom, the United States, and the African Union Commission, the European Union and the …
Side Event: Global Access to Medicinal Cannabis: Programs, Challenges and Solutions
Global Access to Medicinal Cannabis: Programs, Challenges and Solutions Thursday, March 17th, 2020 Sponsored By: Veterans Action Council ENCOD.org Moderator: Etienne Fontanne, Veterans Action Council Speakers: Dr. Pavel Pachta, International Narcotics Control Board (INCB), former Deputy Secretary Dr. Ethan Russo, CReDO Science, Founder and CEO Michael Krawitz, Veterans for Medical Cannabis Access, Executive Director Carola …
Committee of the Whole. L.7. Intensifying efforts to address the proliferation of uncontrolled and designer precursors used in the illicit manufacture of drugs
OP8 Alt & bis United States: We started from the title in informals. We haven’t discussed certain OPs. I don’t believe OP8 Alt & Bis are in a position to be finalised. OP8 is dealing with legislative measures to address the problem of designer precursor chemicals. So it’s a sensitive issue because it’s domestic legislation. …
Opening of the 65th Session of the CND – Plenary Items 1, 2 & 3
Item 1. Election of officers Chair: Welcome. First. Introductory video. CND Secretariat: Welcome. Reminds attendees of the guidelines related to COVID-19. Chair: Wishes good health to people suffering with COVID-19. Before the formal opening, some procedural and organisational matters. Five meetings of the Extended Bureau. Thanks the Ambassador of Poland for her role in conducting the 64th …